154 related articles for article (PubMed ID: 17635154)
1. Protein transduction: identification, characterization and optimization.
Tilstra J; Rehman KK; Hennon T; Plevy SE; Clemens P; Robbins PD
Biochem Soc Trans; 2007 Aug; 35(Pt 4):811-5. PubMed ID: 17635154
[TBL] [Abstract][Full Text] [Related]
2. Characterization of a class of cationic peptides able to facilitate efficient protein transduction in vitro and in vivo.
Mi Z; Mai J; Lu X; Robbins PD
Mol Ther; 2000 Oct; 2(4):339-47. PubMed ID: 11020349
[TBL] [Abstract][Full Text] [Related]
3. Cationic and tissue-specific protein transduction domains identification, characterization, and therapeutic application.
Zahid M; Lu X; Mi Z; Robbins PD
Adv Genet; 2010; 69():83-95. PubMed ID: 20807603
[TBL] [Abstract][Full Text] [Related]
4. A peptide carrier for the delivery of biologically active proteins into mammalian cells.
Morris MC; Depollier J; Mery J; Heitz F; Divita G
Nat Biotechnol; 2001 Dec; 19(12):1173-6. PubMed ID: 11731788
[TBL] [Abstract][Full Text] [Related]
5. The augmentation of intracellular delivery of peptide therapeutics by artificial protein transduction domains.
Yoshikawa T; Sugita T; Mukai Y; Abe Y; Nakagawa S; Kamada H; Tsunoda S; Tsutsumi Y
Biomaterials; 2009 Jul; 30(19):3318-23. PubMed ID: 19304319
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Functional Protein Transduction Domains Using the NEMO Binding Domain Peptide.
Khaja K; Robbins P
Pharmaceuticals (Basel); 2010 Jan; 3(1):110-124. PubMed ID: 27713244
[TBL] [Abstract][Full Text] [Related]
7. Cationic TAT peptide transduction domain enters cells by macropinocytosis.
Kaplan IM; Wadia JS; Dowdy SF
J Control Release; 2005 Jan; 102(1):247-53. PubMed ID: 15653149
[TBL] [Abstract][Full Text] [Related]
8. Identification and characterization of tissue-specific protein transduction domains using peptide phage display.
Zahid M; Robbins PD
Methods Mol Biol; 2011; 683():277-89. PubMed ID: 21053137
[TBL] [Abstract][Full Text] [Related]
9. Gene delivery using a derivative of the protein transduction domain peptide, K-Antp.
Min SH; Kim DM; Kim MN; Ge J; Lee DC; Park IY; Park KC; Hwang JS; Cho CW; Yeom YI
Biomaterials; 2010 Mar; 31(7):1858-64. PubMed ID: 19954838
[TBL] [Abstract][Full Text] [Related]
10. Recent advances in the use of protein transduction domains for the delivery of peptides, proteins and nucleic acids in vivo.
Snyder EL; Dowdy SF
Expert Opin Drug Deliv; 2005 Jan; 2(1):43-51. PubMed ID: 16296734
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of NF-kappaB activation with designed ankyrin-repeat proteins targeting the ubiquitin-binding/oligomerization domain of NEMO.
Wyler E; Kaminska M; Coïc YM; Baleux F; Véron M; Agou F
Protein Sci; 2007 Sep; 16(9):2013-22. PubMed ID: 17766391
[TBL] [Abstract][Full Text] [Related]
12. Dynamic protein complexes regulate NF-kappaB signaling.
Wegener E; Krappmann D
Handb Exp Pharmacol; 2008; (186):237-59. PubMed ID: 18491055
[TBL] [Abstract][Full Text] [Related]
13. Cytoplasmic transduction peptide (CTP): new approach for the delivery of biomolecules into cytoplasm in vitro and in vivo.
Kim D; Jeon C; Kim JH; Kim MS; Yoon CH; Choi IS; Kim SH; Bae YS
Exp Cell Res; 2006 May; 312(8):1277-88. PubMed ID: 16466653
[TBL] [Abstract][Full Text] [Related]
14. The third helix of the murine Hoxc8 homeodomain facilitates protein transduction in mammalian cells.
Kong KA; Gadi J; Park HW; Bok J; Kim MH
Biochem Biophys Res Commun; 2008 Dec; 377(1):161-4. PubMed ID: 18835255
[TBL] [Abstract][Full Text] [Related]
15. Intracellular protein delivery activity of peptides derived from insulin-like growth factor binding proteins 3 and 5.
Goda N; Tenno T; Inomata K; Shirakawa M; Tanaka T; Hiroaki H
Exp Cell Res; 2008 Aug; 314(13):2352-61. PubMed ID: 18602100
[TBL] [Abstract][Full Text] [Related]
16. Comparison of protein transduction domains in mediating cell delivery of a secreted CRE protein.
Shaw PA; Catchpole IR; Goddard CA; Colledge WH
Biochemistry; 2008 Jan; 47(4):1157-66. PubMed ID: 18179254
[TBL] [Abstract][Full Text] [Related]
17. Cell-surface proteoglycans as molecular portals for cationic peptide and polymer entry into cells.
Poon GM; Gariépy J
Biochem Soc Trans; 2007 Aug; 35(Pt 4):788-93. PubMed ID: 17635149
[TBL] [Abstract][Full Text] [Related]
18. A novel, highly selective, tight binding IkappaB kinase-2 (IKK-2) inhibitor: a tool to correlate IKK-2 activity to the fate and functions of the components of the nuclear factor-kappaB pathway in arthritis-relevant cells and animal models.
Mbalaviele G; Sommers CD; Bonar SL; Mathialagan S; Schindler JF; Guzova JA; Shaffer AF; Melton MA; Christine LJ; Tripp CS; Chiang PC; Thompson DC; Hu Y; Kishore N
J Pharmacol Exp Ther; 2009 Apr; 329(1):14-25. PubMed ID: 19168710
[TBL] [Abstract][Full Text] [Related]
19. Transdermal delivery of proteins mediated by non-covalently associated arginine-rich intracellular delivery peptides.
Hou YW; Chan MH; Hsu HR; Liu BR; Chen CP; Chen HH; Lee HJ
Exp Dermatol; 2007 Dec; 16(12):999-1006. PubMed ID: 18031459
[TBL] [Abstract][Full Text] [Related]
20. Cell-penetrating peptides and proteins: new inhibitors of allergic airways disease.
Kinyanjui MW; Fixman ED
Can J Physiol Pharmacol; 2008; 86(1-2):1-7. PubMed ID: 18418441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
